Lightning technology expands upon Treace’s market-leading Lapiplasty ® System with advanced new instrumentation designed to reduce surgical steps, precisely correct in all three planes, and further ...
PONTE VEDRA, Fla., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the ...
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $4.64, a high estimate of $7.00, and a low estimate of $3.00. A decline of 27.73% from the prior ...
About Treace Medical Concepts Inc. Treace Medical Concepts, Inc. engages in the design, manufacture, and marketing of orthopedic medical devices and biologic solutions. It offers Lapiplasty, a bunion ...
As the U.S. market experiences mixed movements, with the Dow advancing while data-storage shares weigh on the Nasdaq, investors are keenly watching for opportunities that might arise from these shifts ...
Preliminary revenue of $62.1 million to $62.5 million in the fourth quarter of 2025, an approximate 9% decrease at the midpoint over the same period in 2024.
(MENAFN- GlobeNewsWire - Nasdaq) PONTE VEDRA, Fla., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the“Company”) (NasdaqGS: TMCI), a medical technology company driving a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback